LEP and ovarian carcinoma: These findings were replicated in vitro, wherein pre-treatment with exogenous leptin was shown to increase resistance to Cisplatin + Paclitaxel and Cisplatin + Taxotere in HO8910PM and OV-MZ-15 ovarian cancer cell lines [49].